A detailed history of Assenagon Asset Management S.A. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 1,389,847 shares of TEVA stock, worth $23.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,389,847
Previous 404,002 244.02%
Holding current value
$23.8 Million
Previous $6.57 Million 281.49%
% of portfolio
0.05%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$15.81 - $18.96 $15.6 Million - $18.7 Million
985,845 Added 244.02%
1,389,847 $25 Million
Q2 2024

Jul 18, 2024

SELL
$12.78 - $17.4 $8.26 Million - $11.3 Million
-646,697 Reduced 61.55%
404,002 $6.57 Million
Q1 2024

Apr 24, 2024

BUY
$10.67 - $14.43 $5.03 Million - $6.8 Million
471,137 Added 81.29%
1,050,699 $14.8 Million
Q4 2023

Jan 17, 2024

BUY
$8.12 - $10.63 $4.12 Million - $5.4 Million
507,568 Added 705.01%
579,562 $6.05 Million
Q3 2023

Nov 06, 2023

SELL
$7.48 - $10.7 $13.2 Million - $18.9 Million
-1,768,279 Reduced 96.09%
71,994 $734,000
Q2 2023

Jul 25, 2023

BUY
$7.2 - $9.47 $13.2 Million - $17.4 Million
1,840,273 New
1,840,273 $13.9 Million
Q4 2022

Jan 12, 2023

BUY
$7.95 - $9.48 $968,055 - $1.15 Million
121,768 Added 13.31%
1,036,449 $9.45 Million
Q3 2022

Oct 27, 2022

BUY
$6.86 - $11.95 $2.62 Million - $4.56 Million
381,618 Added 71.59%
914,681 $7.38 Million
Q2 2022

Jul 27, 2022

SELL
$7.38 - $10.4 $952 - $1,341
-129 Reduced 0.02%
533,063 $4.01 Million
Q1 2022

Apr 25, 2022

SELL
$7.33 - $9.39 $7 - $9
-1 Reduced -0.0%
533,192 $5.01 Million
Q4 2021

Feb 01, 2022

BUY
$7.9 - $10.19 $260,850 - $336,463
33,019 Added 6.6%
533,193 $4.27 Million
Q3 2021

Oct 19, 2021

BUY
$8.38 - $10.18 $4.19 Million - $5.09 Million
500,174 New
500,174 $4.87 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.